経口ドラッグデリバリーシステムの世界市場レポート 2025年

経口ドラッグデリバリーシステムの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.1％で59億7,000万米ドルに成長します。予測期間の成長は、患者中心のドラッグデリバリー、高齢者人口の増加、標的治療、生物製剤、ペプチドデリバリーの需要、規制当局のサポートと承認、研究開発への投資などに起因します。予測期間における主な動向としては、患者の利便性とコンプライアンス、薬剤製剤の進歩、慢性疾患の増加、小児・高齢者医療、バイオアベイラビリティの向上などが挙げられます。

慢性疾患の有病率の増加は、今後の経口ドラッグデリバリーシステム市場の成長を後押しすると予想されます。慢性疾患は、がん、心臓病、脳卒中、糖尿病、関節炎など、1年以上続く健康状態と定義されます。これらの病気は、管理はできても完治はできず、継続的な医療ケアと栄養補給を必要とする、最も一般的な慢性疾患のひとつです。経口ドラッグデリバリーシステムは、糖尿病やがんなどの慢性疾患に苦しむ多くの患者が必要とする粘膜および経粘膜薬剤を投与するための効果的で適切な方法を提供します。例えば、2023年9月、スイスに本部を置く国連の専門機関である世界保健機関（WHO）は、非感染性疾患（NCDs）または慢性疾患により、全体の74％を占める4,100万人が毎年死亡していると報告しました。このうち、心血管疾患による死亡者は1,790万人、がんによる死亡者は930万人、慢性呼吸器疾患による死亡者は410万人、糖尿病による死亡者は200万人です。このように、慢性疾患の有病率の増加が、経口ドラッグデリバリーシステム市場の成長を牽引しています。

病院における需要の高まりは、今後の経口ドラッグデリバリーシステム市場の成長を促進すると予想されます。病院は、病気や怪我をした人に治療、ケア、サービスを提供する専門施設です。病院という環境において、経口ドラッグデリバリーシステムは、迅速な薬物吸収、患者のコンプライアンス強化、消化管副作用の軽減、薬物放出の制御といった利点を提供します。例えば、2023年5月、病院やヘルスケアネットワークを代表する米国のヘルスケア業界団体である米国病院協会（AHA）の報告によると、病院の総数は2022年の6,093施設から6,129施設に増加しました。さらに、米国全病院の総入院者数は3,401万1,386人と、2022年の3,335万6,853人から増加しました。このように、病院での需要の増加が、経口ドラッグデリバリーシステム市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の経口ドラッグデリバリーシステム市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の経口ドラッグデリバリーシステム市場：成長率分析
• 世界の経口ドラッグデリバリーシステム市場の実績：規模と成長、2019～2024年
• 世界の経口ドラッグデリバリーシステム市場の予測：規模と成長、2024～2029年、2034年
• 世界の経口ドラッグデリバリーシステム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経口ドラッグデリバリーシステム市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 舌下投与
• 口腔用錠剤とトローチ
• 経口スプレー
• 世界の経口ドラッグデリバリーシステム市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 疼痛管理
• 禁煙
• 狭心症
• 世界の経口ドラッグデリバリーシステム市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 外来センター
• その他
• 世界の経口ドラッグデリバリーシステム市場：舌下投与のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 舌下錠
• 舌下フィルム
• 世界の経口ドラッグデリバリーシステム市場：口腔内錠剤とトローチのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 口腔内錠剤
• 口腔内トローチ
• 世界の経口ドラッグデリバリーシステム市場：経口スプレーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• スプレー液
• スプレージェル

第7章 地域別・国別分析

• 世界の経口ドラッグデリバリーシステム市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の経口ドラッグデリバリーシステム市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経口ドラッグデリバリーシステム市場：競合情勢
• 経口ドラッグデリバリーシステム市場：企業プロファイル
  • Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Catalent Inc.
• Arx Limited Liability Company
• BioDelivery Science International Incorporated
• Cynapsus Therapeutics Incorporated
• Endo Pharmaceuticals Public Limited Company
• Medlab Clinical Ltd.
• AstraZeneca PLC
• F Hoffmann-La Roche Limited
• Dr. Reddy's Laboratories Ltd.
• Takeda Pharmaceutical Company Limited
• Novartis AG
• Novo Nordisk A/S
• Ethypharm SAS
• Applied Pharma Research SA
• Sunovion Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経口ドラッグデリバリーシステム市場2029年：新たな機会を提供する国
• 経口ドラッグデリバリーシステム市場2029年：新たな機会を提供するセグメント
• 経口ドラッグデリバリーシステム市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

The rising demand in hospitals is expected to drive the growth of the buccal drug delivery systems market in the future. Hospitals are specialized facilities that provide medical treatment, care, and services to individuals who are ill or injured. In hospital settings, buccal drug delivery systems offer benefits such as rapid drug absorption, enhanced patient compliance, reduced gastrointestinal side effects, and controlled drug release. For example, in May 2023, a report from the American Hospital Association (AHA), a US-based healthcare trade organization representing hospitals and healthcare networks, indicated that the total number of hospitals increased to 6,129, up from 6,093 in 2022. Additionally, total admissions across all U.S. hospitals rose to 34,011,386, compared to 33,356,853 in 2022. Thus, the increasing demand in hospitals is propelling the growth of the buccal drug delivery systems market.

Leading companies in the buccal drug delivery systems market are concentrating on creating innovative solutions, such as oral treatments for plaque psoriasis, to enhance patient outcomes and improve drug delivery efficacy. Oral treatments for plaque psoriasis involve administering medications by mouth to manage and relieve the symptoms of this chronic autoimmune disorder, which is characterized by the rapid proliferation of skin cells resulting in thick, red, scaly patches. For example, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults suffering from moderate-to-severe plaque psoriasis. This approval represents the first new oral therapy for this condition in nearly a decade, introducing a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Companies operating in the buccal drug delivery systems market are focusing on product launches to drive revenues. For instance, in February 2023, launch of melatonin oral spray by Arlak Biotech Private Limited. Melatonin oral spray provides an easy and effective way to facilitate the body's natural production of melatonin, aiding in improving sleep quality. This type of product launch addresses specific healthcare needs, contributing to the growth of the buccal drug delivery systems market.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. This strategic acquisition aimed to enhance DifGen's research and development (R&D) and manufacturing capabilities, ensuring a secure supply of high-quality and cost-effective medications. Aveva Drug Delivery Services Inc. specializes in buccal drug delivery systems, aligning with DifGen's goal of providing advanced and reliable pharmaceutical solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
• 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
• 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
• Subsegments:
• 1) By Sublingual: Sublingual Tablets; Sublingual Films
• 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
• 3) By Oral Sprays: Spray Solutions; Spray Gels
• Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Buccal Drug Delivery System Market Characteristics

3. Buccal Drug Delivery System Market Trends And Strategies

4. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Buccal Drug Delivery System Growth Analysis And Strategic Analysis Framework

• 5.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Buccal Drug Delivery System Market Growth Rate Analysis
• 5.4. Global Buccal Drug Delivery System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Buccal Drug Delivery System Total Addressable Market (TAM)

6. Buccal Drug Delivery System Market Segmentation

• 6.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual
• Buccal Tablets And Lozenges
• Oral Sprays
• 6.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Smoking Cessation
• Angina Pectoris
• 6.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Centers
• Other End-Users
• 6.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual Tablets
• Sublingual Films
• 6.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Tablets
• Buccal Lozenges
• 6.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spray Solutions
• Spray Gels

7. Buccal Drug Delivery System Market Regional And Country Analysis

• 7.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Buccal Drug Delivery System Market

• 8.1. Asia-Pacific Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Buccal Drug Delivery System Market

• 9.1. China Buccal Drug Delivery System Market Overview
• 9.2. China Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Buccal Drug Delivery System Market

• 10.1. India Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Buccal Drug Delivery System Market

• 11.1. Japan Buccal Drug Delivery System Market Overview
• 11.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Buccal Drug Delivery System Market

• 12.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Buccal Drug Delivery System Market

• 13.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Buccal Drug Delivery System Market

• 14.1. South Korea Buccal Drug Delivery System Market Overview
• 14.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Buccal Drug Delivery System Market

• 15.1. Western Europe Buccal Drug Delivery System Market Overview
• 15.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Buccal Drug Delivery System Market

• 16.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Buccal Drug Delivery System Market

• 17.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Buccal Drug Delivery System Market

• 18.1. France Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Buccal Drug Delivery System Market

• 19.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Buccal Drug Delivery System Market

• 20.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Buccal Drug Delivery System Market

• 21.1. Eastern Europe Buccal Drug Delivery System Market Overview
• 21.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Buccal Drug Delivery System Market

• 22.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Buccal Drug Delivery System Market

• 23.1. North America Buccal Drug Delivery System Market Overview
• 23.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Buccal Drug Delivery System Market

• 24.1. USA Buccal Drug Delivery System Market Overview
• 24.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Buccal Drug Delivery System Market

• 25.1. Canada Buccal Drug Delivery System Market Overview
• 25.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Buccal Drug Delivery System Market

• 26.1. South America Buccal Drug Delivery System Market Overview
• 26.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Buccal Drug Delivery System Market

• 27.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Buccal Drug Delivery System Market

• 28.1. Middle East Buccal Drug Delivery System Market Overview
• 28.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Buccal Drug Delivery System Market

• 29.1. Africa Buccal Drug Delivery System Market Overview
• 29.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

• 30.1. Buccal Drug Delivery System Market Competitive Landscape
• 30.2. Buccal Drug Delivery System Market Company Profiles
  • 30.2.1. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Buccal Drug Delivery System Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Arx Limited Liability Company
• 31.3. BioDelivery Science International Incorporated
• 31.4. Cynapsus Therapeutics Incorporated
• 31.5. Endo Pharmaceuticals Public Limited Company
• 31.6. Medlab Clinical Ltd.
• 31.7. AstraZeneca PLC
• 31.8. F Hoffmann-La Roche Limited
• 31.9. Dr. Reddy's Laboratories Ltd.
• 31.10. Takeda Pharmaceutical Company Limited
• 31.11. Novartis AG
• 31.12. Novo Nordisk A/S
• 31.13. Ethypharm SAS
• 31.14. Applied Pharma Research SA
• 31.15. Sunovion Pharmaceuticals Inc.

32. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

34. Recent Developments In The Buccal Drug Delivery System Market

35. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

• 35.1 Buccal Drug Delivery System Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Buccal Drug Delivery System Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Buccal Drug Delivery System Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer